The causal role of human papillomavirus infections in cervical cancer has been documented
beyond reasonable doubt. The association is present in virtually all cervical cancer cases …

Epidemiological studies supported by molecular technology have provided sufficient
evidence on the causal role of some Human Papillomavirus (HPV) infections in the …

External genital warts (EGWs) are visible warts that occur in the perigenital and perianal
regions. They are due primarily to non-oncogenic human papillomavirus (HPV) types …

Human papillomavirus is the principal risk factor associated with cervical cancer, the most
common malignancy among women in Colombia. We conducted a survey, aiming to report …

Background: In case–control studies, smoking, parity, and oral contraceptive use have been
associated with an increased risk of cervical intraepithelial neoplasia grade 3 (CIN3) and …

In developing countries, cervical cancer remains a clinical problem of public health
proportions. Eighty percent of the approximately 400,000 new cases of cervical cancer each …

Background: About 80% of cervical cancers occur in less-developed countries. This
disproportionate burden of cervical cancer in such countries is due mainly to the lack of well …

Four-hundred-forty-five husbands of women with invasive cervical carcinoma, 165 of women
with in situ cervical cancer, and 717 of control women (age range 19–82 years) were …

Abstract Hybrid Capture 2 Test using probe B (HC2-B) is a clinical test for the detection of 13
human papillomavirus (HPV) types associated with cervical cancer (oncogenic types), but …

Two modifications to the original L1 consensus primer human papillomavirus (HPV) PCR
method, MY09–MY011, using AmpliTaq DNA polymerase (MY‐Taq), were evaluated for …